Renal Denervation

"The signal has been important and clinically meaningful," says Behnam Tehrani, MD. "At the 90-day visit, we have seen a median blood pressure reduction of over 30 mmHg systolic and 10 mmHg diastolic, with a median reduction of 1.3...

Dr. Orestis Pappas, of Erie, Pennsylvania, shares his clinical experience using the Paradise™ Ultrasound Renal Denervation (uRDN) System (Recor Medical) in a series of patients with uncontrolled hypertension under his care. He reflects on his...

VDM spoke with interventional radiologist Lindsay Machan, MD, from Vancouver Hospital in Canada, to discuss his presentation on selecting patients for renal denervation treatment.

Joachim Weil, MD, presented a pooled analysis from the SPYRAL HTN-ON and OFF MED studies assessing blood pressure changes in 388 RDN patients stratified by Medicare-eligible age — those under 65 years and those 65 years and older, over a...

Dr. Jeremy Bock discusses his study looking at blood pressure response following radiofrequency renal denervation in the largest real-world United States cohort, including older patients, recently presented at the CRT meeting in Washington,...

The Paradise ultrasound Renal Denervation (uRDN) System (Recor Medical, Inc.) uses circumferential ultrasound energy to thermally ablate and disrupt sympathetic nerves along the renal arteries.

The authors describe the role of dynamic road-mapping for renal denervation.